Your browser doesn't support javascript.
loading
Comparing suicide completion rates in bipolar I versus bipolar II disorder: A systematic review and meta-analysis.
Dev, Donovan A; Le, Gia Han; Kwan, Angela T H; Wong, Sabrina; Arulmozhi, Akhilan; Ceban, Felicia; Teopiz, Kayla M; Meshkat, Shakila; Rosenblat, Joshua D; Guillen-Burgos, Hernan F; Rhee, Taeho Greg; Ho, Roger C; Cao, Bing; d'Andrea, Giacomo; Sundberg, Isak; McIntyre, Roger S.
Afiliación
  • Dev DA; Brain and Cognition Discovery Foundation, Toronto, ON, Canada; School of Medicine, University College Dublin, Dublin, Ireland; Department of Neuroscience Imaging and Clinical Sciences, University G d'Annunzio, Chieti, Italy. Electronic address: donovan.adev@gmail.com.
  • Le GH; Brain and Cognition Discovery Foundation, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. Electronic address: hanny.le@mail.utoronto.ca.
  • Kwan ATH; Brain and Cognition Discovery Foundation, Toronto, ON, Canada; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. Electronic address: angela.kwan@mail.utoronto.ca.
  • Wong S; Brain and Cognition Discovery Foundation, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada. Electronic address: sabrinal.wong@mail.utoronto.ca.
  • Arulmozhi A; Brain and Cognition Discovery Foundation, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
  • Ceban F; Brain and Cognition Discovery Foundation, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: felicia.ceban@mail.utoronto.ca.
  • Teopiz KM; Brain and Cognition Discovery Foundation, Toronto, ON, Canada. Electronic address: kayla.teopiz@mail.utoronto.ca.
  • Meshkat S; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
  • Rosenblat JD; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toront
  • Guillen-Burgos HF; Center for Clinical and Translational Research, Universidad Simón Bolívar, Barranquilla, Colombia; Center for Clinical and Translational Research, Faculty of Medicine, Universidad El Bosque, Bogotá D.C., Colombia; Department of Psychiatry and Mental Health, Pontificia Universidad Javeriana, Bogotá D
  • Rhee TG; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA; Department of Public Health Sciences, University of Connecticut School of Medicine, Farmington, CT, USA. Electronic address: taeho.rhee@yale.edu.
  • Ho RC; Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore 117599, Singapore.; Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore. Electronic address: pcmrhcm@nus.edu.sg.
  • Cao B; Key Laboratory of Cognition and Personality (SWU), Faculty of Psychology, Ministry of Education, Southwest University, Chongqing 400715, PR China. Electronic address: bingcao@swu.edu.cn.
  • d'Andrea G; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Sundberg I; Department of Neuroscience Psychiatry, Uppsala University Hospital, Uppsala, Sweden. Electronic address: isak.sundberg@neuro.uu.se.
  • McIntyre RS; Brain and Cognition Discovery Foundation, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; School of Medicine, University College Dublin, Dublin, Ireland; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada; Department of Psychiat
J Affect Disord ; 361: 480-488, 2024 Sep 15.
Article en En | MEDLINE | ID: mdl-38901691
ABSTRACT

BACKGROUND:

Bipolar disorder (BD) has a high disease burden and the highest mortality risk in BD comes from suicide. Bipolar disorder type II (BD-II) has been described as a milder form of bipolar disorder; however, extant literature is inconsistent with this description and instead describe illness burden and notably suicidality comparable to persons with bipolar I disorder (BD-I). Towards quantifying the hazard of BD-II, herein we aim via systematic review and meta-analysis to evaluate the rates of completed suicide in BD-I and BD-II.

METHOD:

We conducted a literature search on PubMed, OVID (Embase, Medline) and PsychINFO databases from inception to June 30th, 2023, according to PRISMA guidelines. Articles were selected based on the predetermined eligibility criteria. A meta-analysis was performed, comparing the risk of completed suicide between individuals diagnosed with BD-I to BD-II.

RESULTS:

Four out of eight studies reported higher suicide completion rates in persons living with BD-II when compared to persons living with BD-I; however, two of the studies reported non-significance. Two studies reported significantly higher suicide completion rates for BD-I than BD-II. The pooled odds ratio of BD-II suicide rates to BD-I was 1.00 [95 % CI = 0.75, 1.34].

LIMITATIONS:

The overarching limitation is the small number of studies and heterogeneity of studies that report on suicide completion in BD-I and BD-II.

CONCLUSION:

Our study underscores the severity of BD-II, with a risk for suicide not dissimilar from BD-I. The greater propensity to depression, comorbidity and rapid-cycling course reported in BD-II are contributing factors to the significant mortality hazard in BD-II.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Bipolar / Suicidio Completo Límite: Humans Idioma: En Revista: J Affect Disord Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Bipolar / Suicidio Completo Límite: Humans Idioma: En Revista: J Affect Disord Año: 2024 Tipo del documento: Article
...